tiprankstipranks
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market
IDXG
Interpace Diagnostics Group
RESEARCH TOOLSreports

Interpace Diagnostics Group (IDXG) Income Statement

413 Followers

Interpace Diagnostics Group Income Statement

Last quarter (Q4 2025), Interpace Diagnostics Group's total revenue was $9.22M, a decrease of -25.10% from the same quarter last year. In Q4, Interpace Diagnostics Group's net income was $22.66M. See Interpace Diagnostics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 38.73M$ 46.93M$ 40.21M$ 31.84M$ 41.31M
Gross Profit
$ 24.13M$ 29.93M$ 23.90M$ 18.23M$ 17.95M
Operating Expenses
$ 20.05M$ 21.82M$ 21.10M$ 22.07M$ 29.68M
Depreciation and Amortization
$ 821.00K$ 748.00K$ 1.03M$ 2.56M$ 5.37M
EBITDA
$ 4.76M$ 8.36M$ 3.84M$ -2.27M$ -1.33M
Operating Income
$ 4.08M$ 8.11M$ 2.80M$ -3.84M$ -11.74M
Other Income/Expenses
$ -310.00K$ -1.16M$ -1.68M$ -2.22M$ -1.41M
Pretax Income
$ 3.77M$ 6.95M$ 1.13M$ -5.84M$ -15.41M
Net Income
$ 24.57M$ 6.70M$ 802.00K$ -5.87M$ -14.75M
Per Share Metrics
Basic EPS
$ 5.55$ 1.42$ 0.19$ -1.38$ -3.57
Diluted EPS
$ 0.89$ 0.40$ 0.18$ -1.38$ -3.57
Weighted Average Shares Outstanding
 4.42M 4.39M 4.32M 4.24M 4.13M
Weighted Average Shares Outstanding (Diluted)
 27.70M 4.39M 4.36M 4.24M 4.13M
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History